Home/Filings/4/0001179110-11-007981
4//SEC Filing

Cameron Tammy 4

Accession 0001179110-11-007981

CIK 0001005201other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 8:29 PM ET

Size

18.8 KB

Accession

0001179110-11-007981

Insider Transaction Report

Form 4
Period: 2011-05-11
Cameron Tammy
VP, Finance
Transactions
  • Exercise/Conversion

    Common Stock

    2011-05-11$1.98/sh+30,000$59,40040,054 total
  • Exercise/Conversion

    Common Stock

    2011-05-11$1.83/sh+17,742$32,46827,796 total
  • Exercise/Conversion

    Common Stock

    2011-05-12$1.83/sh+18,821$34,44228,875 total
  • Sale

    Common Stock

    2011-05-11$8.61/sh30,000$258,36010,054 total
  • Sale

    Common Stock

    2011-05-11$8.36/sh17,742$148,27010,054 total
  • Sale

    Common Stock

    2011-05-12$8.26/sh18,821$155,36710,054 total
  • Exercise/Conversion

    Stock Option

    2011-05-1130,0000 total
    Exercise: $1.98Exp: 2017-08-24Common Stock (30,000 underlying)
  • Exercise/Conversion

    Stock Option

    2011-05-1117,74247,258 total
    Exercise: $1.83Exp: 2019-01-23Common Stock (17,742 underlying)
  • Exercise/Conversion

    Stock Option

    2011-05-1218,82128,437 total
    Exercise: $1.83Exp: 2019-01-23Common Stock (18,821 underlying)
Footnotes (5)
  • [F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.53 to $8.80. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
  • [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.35 to $8.38. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
  • [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.25 to $8.28. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each price within the range set forth in this footnote.
  • [F4]Exercisable on 8/24/2008 with respect to 50% of the underlying shares and monthly thereafter.
  • [F5]Exercisable in 48 equal monthly installments.

Issuer

DEPOMED INC

CIK 0001005201

Entity typeother

Related Parties

1
  • filerCIK 0001415245

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 8:29 PM ET
Size
18.8 KB